{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT03140969: Phase 1/Phase 2 Interventional Completed Leber's Congenital Amaurosis
(2017)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT02226965: Phase 2 Interventional Completed Lymphoma, Diffuse Large B-Cell
(2014)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04516291: Phase 2 Interventional Completed Dyslipidemias
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03865082: Phase 2 Interventional Active, not recruiting Solid Tumor
(2019)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03842969: Phase 3 Interventional Completed Huntington Disease
(2019)
Source URL:
Class:
NUCLEIC ACID